Day: September 29, 2025

Contract Wins Total Nearly 3,600 beds BRENTWOOD, Tenn., Sept. 29, 2025 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (“CoreCivic”) announced today that it has been awarded two new contracts with U.S. Immigration and Customs Enforcement (“ICE”) to utilize 3,593 beds at two facilities we own in core enforcement areas of the United States. Once fully activated, we expect to generate total annual revenue at the two facilities combined of nearly $200 million.California City Immigration Processing Center – 2,560 bedsNew contract with ICE to utilize our 2,560-bed California City Immigration Processing Center.  We have been preparing to accept detainees at this facility since April 1, 2025, when we entered into a six-month Letter Contract with ICE to resume operations at the facility while we worked to...

Back-to-back deals accelerate growth and reinforce Aeries’ AI-enabled GCC model NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (NASDAQ: AERT), a global leader in AI-powered business transformation and Global Capability Center (GCC) services, said that two recently secured enterprise engagements are expected to drive a combined annualized revenue run-rate above $20 million by March 2026, based on current scope, with further growth anticipated.$8M+ AI deal (Sept. 18): A multi-year partnership with a global marketing and technology company to establish its India footprint and scale AI delivery. The engagement will build production-grade AI systems, intelligent data pipelines, and decisioning tools. $12M+ expansion (Sept. 24): A broadened engagement with a global enterprise client, expected to exceed $12 million...

EL SEGUNDO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND) (the “Company”), a leader in plant-based meat, today announced that it has commenced an exchange offer (the “Exchange Offer”) to exchange any and all of its 0% Convertible Senior Notes due 2027 (the “Existing Convertible Notes”) for a pro rata portion of (i) up to $202.5 million in aggregate principal amount of its new 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 (the “New Convertible Notes”) and (ii) up to 326,190,370 shares of its common stock. Beyond Meat President and CEO Ethan Brown commented, “As we continue our business transformation, we have simultaneously worked to strengthen our balance sheet and are today pleased to announce that we are launching an Exchange Offer for our Existing Convertible Notes. The Exchange...

Paris, France – September 29, 2025 – Eviden, the Atos Group product brand leading in advanced computing, cybersecurity products, mission-critical systems and vision AI today announces a strategic partnership with Vates, a pioneering company in open-source virtualization solutions, to provide a European reliable, efficient, and future-proof virtualization solution, ready to meet real-world infrastructure demands. In a context where sovereignty, transparency, and control are increasingly strategic, this partnership between two European companies will open new possibilities for customers looking to reduce their reliance on foreign vendors. Together, Eviden and Vates aim at delivering a 100% sovereign infrastructure stack from the hardware to the virtualization platform. By combining Eviden’s latest BullSequana SH servers, its enterprise servers...

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that the independent directors of the Board have unanimously appointed Dr. Ted W. Love, an independent director since 2020, as Lead Independent Director. Dr. Love will continue to Chair the Nominating and Corporate Governance Committee. “I am delighted to welcome Ted to the key role of Lead Independent Director,” said Pablo Legorreta, Chief Executive Officer of Royalty Pharma and Chairman of the Board. “Ted has extensive research-based biopharma experience gained over a long and successful career and currently serves as Immediate Past Chairman of the Biotechnology Innovation Organization’s (BIO) Board of Directors. Ted has consistently demonstrated exceptional judgment and leadership, and we look forward to his continued stewardship as...

Nes-Ziona, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, will participate in a live investor webinar, “Advancing Inflammatory Disease Treatment: Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program,” hosted by D. Boral Capital on September 30, 2025, at 10:00 AM Eastern Time. The discussion will bring together leading key opinion leaders (KOLs) in musculoskeletal disease, alongside Enlivex’s Vice Chairman and D. Boral’s Research Director.   The September 30 KOL webinar will explore recent breakthroughs in treatment approaches discussing the positive Phase IIa topline data from Enlivex’s Allocetra™ program in moderate-to-severe knee osteoarthritis (KOA) patients. Data demonstrated...

Select units of Cosentyx to be made available at 55% discount off list price on direct-to-patient (DTP) platform beginning November 1, 2025DTP offering to expand to other appropriate products; exploring additional direct-to-employer model to increase access and affordability for cash-paying patients in the USBasel, September 29, 2025 – Today, Novartis announced plans to launch a direct-to-patient (DTP) platform in the US which will come into effect on November 1, 2025, offering cash-paying patients prescribed Cosentyx® (secukinumab) the option to purchase it at a 55% discount off the list price. Cosentyx, Novartis top selling product in the US, is a biologic that is FDA-approved for the treatment of multiple immune-mediated inflammatory diseases, including psoriasis, hidradenitis suppurativa and psoriatic arthritis. It has been studied...

Ruggedized, AI-Driven Edge Computing Platform for Military and Homeland Security Applications Rehovot, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and artificial intelligence (“AI”) – based edge computing technology, today announced the launch of Peridot Night, a situational awareness and terrain dominance solution designed to enhance visibility, safety, and operational decision-making across ground, aerial, and maritime platforms, as well as fixed locations. Peridot Night will be premiered at AUSA 2025 (Association of the United States Army), at Maris-Tech’s booth #2154, Hall B. Click here to schedule a demo. Powered by Maris’ Jupiter-AI edge computing platform, Peridot Night integrates three thermal and one full-HD day camera to deliver...

HSDT Solana Company’s Mission is to maximize SOL per share on one of the most commercially viable blockchains for consumer applications while delivering consistent on-chain yield for investors HSDT enters into agreement with the Solana Foundation to establish its collaboration and commit to joint initiatives This signifies HSDT’s commitment to building a long-lasting institution that accelerates the growth of Solana and being a powerful advocate for Solana’s development alongside the independent Solana Foundation and Solana Lab NEWTOWN, Pa., Sept. 29, 2025 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“HSDT” or the “Company”) announced that, following receipt of approval from its Board of Directors, it has filed an amendment to its Certificate of Incorporation with the Delaware Secretary of State...

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) —  Getty Images Holdings, Inc. (NYSE: GETY) (“Getty Images”) announced today that its indirect wholly owned subsidiary, Getty Images, Inc. (the “Issuer”), plans to offer, in a private offering, subject to market and other conditions, $628,400,000 aggregate principal amount of senior secured notes due 2030 (the “Notes”). The Notes will be senior secured obligations of the Issuer and will be jointly and severally guaranteed on a senior secured first lien basis by the same guarantors that provide guarantees for the Issuer’s outstanding senior secured notes due 2030 and its secured credit facility. The offering is being made in connection with the previously announced proposed merger (the “Merger”) with Shutterstock, Inc. (“Shutterstock”), to create a premier visual content company. An amount...